Kare Chemical Technologies pharmaceutical‑technology company focused on synthetic cannabinoids and related drug‑discovery platforms.
Kare Chemical Technologies has raised $366K in total funding. The most recent round was Pre-Seed. The last funding was announced in May 2026.
Kare Chemical Technologies's investors include Ontario Centre of Innovation.
Kare Chemical Technologies is headquartered in Mississauga, Canada.
Kare Chemical Technologies pharmaceutical‑technology company focused on synthetic cannabinoids and related drug‑discovery platforms.
Kare Chemical Technologies is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kare Chemical Technologies — Funding & Investors." VCBacked, May 11, 2026, https://www.vcbacked.co/company/kare-chemical-technologies. Accessed October 30, 2026.
VCBacked. (2026). Kare Chemical Technologies — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/kare-chemical-technologies
{{cite web |title=Kare Chemical Technologies — Funding & Investors |url=https://www.vcbacked.co/company/kare-chemical-technologies |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated